Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

The following is the Dec. 30, 2025, Congressional Research Service report, Navy Guided Missile Battleship (BBG[X]) Program: ...

Maintainers and developers are now using AI to help build Linux. Simultaneously, Rust has graduated to being a co-equal language with C for mainstream Linux development. However, the programming world ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

For a Summer Undergraduate Research Fellowship project, Carnegie Mellon University sophomore Jasmine Li worked with robotic arms in the Robotic Caregiving and Human Interaction Lab to analyze the ...

The presenter does a really excellent job of explaining the value and power of ChatGPT's collaborative editing feature, called Canvas. He also has a creatively bizarre filming set with a pool table, a ...

Whether you’re setting out on a course of academic study that will define your professional life, or seeking to build skills to help you land a better job, Santa Clara’s graduate programs offer a ...

Our summer interns gain an insider’s view of the member-country-focused mandate and critical international work of the IMF. You will build professional networks while you apply your research and ...

Troy Segal is an editor and writer. She has 20+ years of experience covering personal finance, wealth management, and business news. Collateralized loan obligations (CLOs) are structured securities ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on knowledge of ...